Ann: June Quarterly Activities Report, page-8

  1. 104 Posts.
    looking forward to this announcement when it happens
    been 9 weeks now
    surely next week

    from the 1/8/22
    4) Separate to our clinical trial efforts the Company is also aggressively pursuing multiple other business development opportunities for the licensing of its SphygmoCor® technology to third-party medical device companies. We anticipate an announcement regarding the first of these new efforts in the next 4-6 weeks.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $17.49M
Open High Low Value Volume
4.1¢ 4.1¢ 3.9¢ $2.629K 66.37K

Buyers (Bids)

No. Vol. Price($)
1 50000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 157414 2
View Market Depth
Last trade - 13.42pm 24/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.